Deals
Top Allergan holder Paulson urges deal with Shire: sources
Allergan Inc (AGN.N) shareholder Paulson & Co is urging the Botox maker to merge with specialty pharmaceutical company Shire Plc (SHP.L) as an alternative to a deal with hostile bidder Valeant Pharmaceuticals International Inc (VRX.TO), according to two people familiar with the matter.
AbbVie says $55 billion acquisition of Shire officially dead
U.S. drugmaker AbbVie Inc (ABBV.N) said on Monday it has reached agreement with Shire Plc (SHP.L) to officially call off its proposed $55 billion purchase of the Irish company, and will pay Shire a $1.64 billion breakup fee for walking away from the deal.
Virgin Money postpones London stock market listing
UK lender Virgin Money has postponed its London stock market listing, the company said on Friday, delaying plans to raise around 150 million pounds ($241.5 million) in a float that could have valued the firm at 1.5-2 billion pounds ($2.4-3.2 billion).
Yahoo set to outline cost-cutting efforts
Yahoo Inc is expected on Tuesday to outline cost-cutting efforts and give details of how it is evaluating possible acquisitions as it faces pressure from an activist investor, the Wall Street Journal reported, citing a person who was briefed on the plan.